Funder
Indian Council of Medical Research
Publisher
Springer Science and Business Media LLC
Reference93 articles.
1. Ahmad I, Shaikh M, Surana S, Ghosh A, Patel H (2020) p38α MAP kinase inhibitors to overcome EGFR tertiary C797S point mutation associated with osimertinib in non-small cell lung cancer (NSCLC): emergence of fourth-generation EGFR inhibitor. J Biomol Struct Dyn 1–14
2. Ahmad I, Kumar D, Patel H (2021a) Computational investigation of phytochemicals from Withania somnifera (Indian ginseng/ashwagandha) as plausible inhibitors of GluN2B-containing NMDA receptors. J Biomol Struct Dyn 10:1–13
3. Ahmad I, Jadhav H, Shinde Y, Jagtap V, Girase R, Patel H (2021b) Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors. In Silico Pharmacol 23(9):23
4. Amala M, Rajamanikandan S, Prabhu D, Surekha K, Jeyakanthan J (2019) Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches. J Biomol Struct Dyn 37(2):394–410
5. Benet LZ, Hosey CM, Ursu O, Oprea TI (2016) BDDCS, the rule of 5 and drugability. Adv Drug Deliv Rev 101:89–98
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献